Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01762683
Other study ID # LIRUSSI-AOI-2011
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 6, 2012
Est. completion date January 15, 2016

Study information

Verified date January 2013
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to improve the understanding of cellular mecanism involved in delivery disorders in obese women, first by characterizing the hyperplasia phenomenon of myometrail cells induced by inflammatory stimulation (Il-1B), then by studying the role of blood mononuclear cells, of leptine and of obese women sera to interfere with the transition of myometrial cells toward hyperplasia phenotype.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date January 15, 2016
Est. primary completion date January 15, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Informed consent signed

- Patient affiliated with a social security scheme

- In front of for obstetrical reasons to give birth by caesarean section (scheduled caesarean section)

- Or a woman who is not obese in labour and needs to undergo a cesarean section

- No obvious infectious context

- Age > 18 years old

Exclusion Criteria:

- Obvious inflammatory or autoimmune diseases

- Suspected or confirmed infectious context, including virale infection VIH, VHC, VHB

- Coagulation disorders

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Myometrium biopsy and blood samples
The biopsy of myometrium is specially realised for the study in surgical unit after the release of the child, in women with normal pregnancy but necessitating a caesarean. The blood samples are realised, specially for the study, either during the medical exam before the ceasarean or specifically for the study.

Locations

Country Name City State
France Clinique Sainte Marthe Dijon
France Maternité du CHU de Dijon Dijon Bourgogne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measuring the expression level of markers (Gama actine, Desmine, Connexine-43, and Ocytocine receptor) by Westernblotting Demonstrate in vitro the capacity of a Il-1B stimulus to induce the differentiation of the myometrial cells toward a hyperplasia phenotype, and that the answer depends on whether this is cells from normal weight women or obese women before conception. up to 2 months
See also
  Status Clinical Trial Phase
Completed NCT03626597 - Community-based Provision of Urine Pregnancy Tests as Linkage to Reproductive Health Services N/A
Enrolling by invitation NCT01019785 - Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial Phase 3
Recruiting NCT02372487 - Sildenafil Citrate Therapy for Oligohydramnios N/A
Completed NCT02362399 - Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses N/A
Completed NCT00901758 - Intravenous (IV) Nitroglycerin for Versions in Multiparous Women N/A
Recruiting NCT06113237 - Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy